Evidence map›Paper›PMID 36595959›Full record

ArticleSTAR protocols2022

Deconvolution of in vivo protein-RNA contacts using fractionated eCLIP-seq.

Giulia Biancon, Emma Busarello, Poorval Joshi, Bluma J Lesch, Stephanie Halene, Toma Tebaldi

Open access · goldAbstract read
In one paragraph

Article in STAR protocols, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Giulia BianconSection of Hematology, Department of Internal Medicine, Yale Comprehensive Cancer Center, Yale University School of Medicine, New Haven, CT, USA. Electronic address: giulia.biancon@yale.edu.
Emma BusarelloDepartment of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.
Poorval JoshiSection of Hematology, Department of Internal Medicine, Yale Comprehensive Cancer Center, Yale University School of Medicine, New Haven, CT, USA.
Bluma J LeschDepartment of Genetics, Yale University School of Medicine, New Haven, CT, USA.
Stephanie HaleneSection of Hematology, Department of Internal Medicine, Yale Comprehensive Cancer Center, Yale University School of Medicine, New Haven, CT, USA; Yale Stem Cell Center, Yale University School of Medicine, New Haven, CT, USA; Yale Center for RNA Science and Medicine, Yale University School of Medicine, New Haven, CT, USA; Department of Pathology, Yale University School of Medicine, New Haven, CT, USA. Electronic address: stephanie.halene@yale.edu.
Toma TebaldiSection of Hematology, Department of Internal Medicine, Yale Comprehensive Cancer Center, Yale University School of Medicine, New Haven, CT, USA; Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy. Electronic address: toma.tebaldi@unitn.it.
Yale Cancer Center · USUniversity of Trento · ITYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Proteomics CoreU54DK110858 · NIDDK · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Anna E Beaudin, JAMES Eric COX · 2016 to 2026
$8.6M
Hematology Central Coordinating Center (HCCC) for the NIDDK Hematology Centers ProgramU24DK126127 · NIDDK · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Anna E Beaudin, DEREK L STIREWALT · 2020 to 2026
$7.5M
Germline Utx mutation as a model for transgenerational epigenetic inheritanceR01HD098128 · NICHD · YALE UNIVERSITY · PI LESCH, BLUMA J · 2020 to 2024
$2.0M
The role of mutant splicing factor SRSF2 in MyelodysplasiaR01DK102792 · NIDDK · YALE UNIVERSITY · PI HALENE, STEPHANIE · 2016 to 2019
$1.5M
The role of m6A RNA modification as modulator of dsRNA induced cell-intrinsic innate immune responses in hematopoiesisR01DK124788 · NIDDK · YALE UNIVERSITY · PI HALENE, STEPHANIE · 2021 to 2023
$884k
NCATS NIH HHS UL1 TR001863NICHD NIH HHS R01 HD098128NIDDK NIH HHS R01 DK102792NIDDK NIH HHS R01 DK124788NIDDK NIH HHS U24 DK126127NIDDK NIH HHS U54 DK110858
6 · The paper itself

Abstract

Thousands of RNA-binding proteins orchestrate RNA processing and altered protein-RNA interactions frequently lead to disease. Here, we present experimental and computational analysis pipelines of fractionated eCLIP-seq (freCLIP-seq), a modification of enhanced UV-crosslinking and RNA immunoprecipitation followed by sequencing. FreCLIP-seq allows transcriptome-wide analysis of protein-RNA interactions at single-nucleotide level and provides an additional level of resolution by isolating binding signals of individual RNA-binding proteins within a multicomponent complex. Binding occupancy can be inferred from read counts and crosslinking events. For complete details on the use and execution of this protocol, please refer to Biancon et al. (2022).

Indexed as

RNATranscriptomeBinding SitesHigh-Throughput Nucleotide SequencingRNA-Binding ProteinsRNARNA-Binding ProteinsBioinformaticsCell BiologyMolecular BiologyProtein BiochemistryProtein expression and purificationRNAseqSequencing

Identifiers

PMID36595959
PMCPMC9676202
OpenAlexW4309333102

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.